BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)
| 1.19 BATS BZX Real-Time Price As of Jun 28 |  0.00 / 0.00%Today’s Change | 1.00 Today|||52-Week Range 4.19 | -49.36% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $22.2M |
Company Description
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Contact Information
BiondVax Pharmaceuticals Ltd. Jerusalem BioPark Jerusalem Jerusalem 74036 |
Employees
Shareholders
| Other institutional | 1.41% |
| Mutual fund holders | 0.34% |
| Individual stakeholders | -- |
Top Executives
| Amir Reichman | Chief Executive Officer & Director |
| Elad Mark | Chief Operating Officer |
| Uri Ben-Or | Chief Financial Officer |
| Tamar Ben-Yedidia | Chief Science Officer |
| Dalit Weinstein Fischer | Head-Technical, Research & Development |
